← All stocks

Kyverna Therapeutics, Inc.

KYTX Net buying

CIK 0001994702 #3077 in the set updated 19 Sep 2026

Bought (12 mo)

$2.00M

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$292.78K

$0.00 on a plan · $292.78K straight out of an exercise

Sold at will

$0.00

0 of 1 sales

Net

+$1.71M

+$2.00M against sales at will

By person

14 insiders · 3 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

SEIDENBERG BETH C

Director

$1,000.00K (1)

—

+$1,000.00K

891,044

1.44%

$6.68M

+21.1%

Westlake BioPartners Opportunity Fund I, L.P. entity

10% owner

$1,000.00K (1)

—

+$1,000.00K

869,317

1.41%

$6.52M

+18.1%

Walker Karen Marie

Chief Technology Officer

—

$292.78K (1) scheduled

−$292.78K

22,636

0.0366%

$169.77K

+134.9%

Shaw Christi

Executive Chairperson

—

66,741

0.1079%

$500.56K

—

Biddle Warner Weston

Chief Executive Officer

—

58,000

0.0938%

$435.00K

—

Jones Ryan Alexander

Chief Financial Officer

—

55,950

0.0905%

$419.63K

+27.3%

CLARK IAN T

Director

—

21,727

0.0351%

$162.95K

—

Cohen Fred E

Director

—

21,727

0.0351%

$162.95K

—

Aktar Mert

Director

—

21,727

0.0351%

$162.95K

—

GEHCHAN NAJI

See Remarks

—

18,000

0.0291%

$135.00K

—

SPIEGELMAN DANIEL K

Director

—

16,634

0.0269%

$124.76K

—

Emany Sravan Kumar

Director

—

11,006

0.0178%

$82.55K

—

Miller Andrew Craig

Director

—

11,006

0.0178%

$82.55K

—

GRASSO MARC

Chief Financial Officer

—

10,000

0.0162%

$75.00K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Westlake BioPartners Opportunity Fund I, L.P.

18 Dec 2025

10% owner

Buy indirect

133,333

$7.50

$1,000.00K

SEIDENBERG BETH C

18 Dec 2025

Director

Buy indirect

133,333

$7.50

$1,000.00K

Show all 3 transactions →

What was left out

Form 4 filings counted 17

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 1

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 1

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 210,877

History held since 12 Feb 2024